SBS Day 2 - Disease Prevention in T1D and Neonates Panel

Panel
III-a:
Moderators
: Joseph Hedrick and Klaus Romero (C-Path)
Panelists
: Justin Earp (FDA),Larissa Lapteva (FDA), Esther Latres (JDRF), Melissa Lestini (FDA), Justin Penzenstadler (FDA), StefanyShaheen (T1D Patient Advocate), Jim Wilson (Penn)
This Critical Path Institute summit featured presentations and panel discussions with C-Path collaborators from industry, academia, global regulatory agencies, nurses, parents and patients. The workshop:
- Explored the unmet needs and potential solutions relevant to specific aspects of type-1 diabetes, alpha-1 antitrypsin deficiency, lysosomal diseases, and neonatal indications.
- Demonstrated the critical role data sharing plays in enhancing drug development for vulnerable patient populations with conditions that require interventions early in life.
- Reviewed the current landscape of regenerative therapies, identifying regulatory opportunities that could expedite the development of such groundbreaking products.
- Please check back in for recordings from our sessions, to be posted below.
Contact [e-mail] if you have any questions.